Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus for Refractory Autoimmune Cytopenia
NCT03918265Phase 4Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2019
- Primary completion
- Aug 2020
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in autoimmune hemolytic anemia (AIHA), pure red cell aplasia (PRCA), Evans syndrome, sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
tacrolimus
03
Conditions
autoimmune hemolytic anemia (AIHA)pure red cell aplasia (PRCA)Evans syndrome
Beyond the preview
Go deeper on NCT03918265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03918265.